What does PHARMACIE FIORE do?

PHARMACIE FIORE is a logistics company in Verviers. Private Limited, started on 4 October 1973, 1 establishment.

What is the address of PHARMACIE FIORE?

The registered office of PHARMACIE FIORE is located at Place du Marché 10, 4800 Verviers.

Is PHARMACIE FIORE still active?

Yes. According to the CBE (29 October 2026) PHARMACIE FIORE is active, legal situation “Normale toestand”, started on 4 October 1973.

Is PHARMACIE FIORE registered on Peppol?

Yes, PHARMACIE FIORE is registered on the Peppol network with ID 0208:0413622351.

What is the enterprise number of PHARMACIE FIORE?

The enterprise number of PHARMACIE FIORE is BE0413622351.

When was PHARMACIE FIORE founded?

PHARMACIE FIORE was founded on 4 October 1973.

Who are the directors of PHARMACIE FIORE?

According to the 2025 annual accounts, the directors of PHARMACIE FIORE are: FIANNCIERE SJSF, FINANCIERE DE VERVIERS.

Is PHARMACIE FIORE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 October 1973; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did PHARMACIE FIORE make in 2025?

PHARMACIE FIORE posted a profit after taxes of € 188,106 in financial year 2025.

What is the revenue of PHARMACIE FIORE?

As a small company, PHARMACIE FIORE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 411,085.

How much does an employee at PHARMACIE FIORE earn?

The average wage cost per full-time employee at PHARMACIE FIORE was € 45,700 in 2025: staff costs of € 192,094 for 4.2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE FIORE have?

According to the 2025 annual accounts, PHARMACIE FIORE has 4.2 full-time equivalents (FTE).

PHARMACIE FIORE (Private Limited) - Verviers

Dossier PHARMACIE FIORE, printed on 29 October 2026 from databakkes.be/en/0413622351/pharmacie-fiore. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACIE FIORE from Verviers, company number BE0413622351, closed financial year 2025 with a result of € 188,106 after tax. For that financial year PHARMACIE FIORE recorded a gross margin of € 411,085 and equity of € 452,803. Compared with financial year 2024, the result moved from € 149,248 to € 188,106. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 9, 2026.

What it is worth Growing

€ 452,803

▲ 9% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 188,106

▲ 26% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 142,887

▲ 30% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 150,000 paid out

80 % of the profit went to the shareholders, mostly to FINANCIERE DE VERVIERS (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

4.2

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 192,094

▼ 2% vs 2024

€ 45,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 105,020

▼ 22% vs 2024

€ 39,530 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 138,751

▼ 30% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 46,093

▲ 19% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 318,456 Gross margin 2022: € 318,456 First fiscal year in the series	€ 354,376 Gross margin 2023: € 354,376 ▲ 11% vs 2022 (€ 318,456) Favourable step	€ 404,832 Gross margin 2024: € 404,832 ▲ 14% vs 2023 (€ 354,376) Favourable step	€ 411,085 Gross margin 2025: € 411,085 ▲ 2% vs 2024 (€ 404,832) Favourable step	▲ 2%
Profit after taxes	€ 100,788 Profit after taxes 2022: € 100,788 First fiscal year in the series	€ 78,962 Profit after taxes 2023: € 78,962 ▼ 22% vs 2022 (€ 100,788) Unfavourable step	€ 149,248 Profit after taxes 2024: € 149,248 ▲ 89% vs 2023 (€ 78,962) Favourable step	€ 188,106 Profit after taxes 2025: € 188,106 ▲ 26% vs 2024 (€ 149,248) Favourable step	▲ 26%
Equity	€ 371,487 Equity 2022: € 371,487 First fiscal year in the series	€ 385,449 Equity 2023: € 385,449 ▲ 4% vs 2022 (€ 371,487) Favourable step	€ 414,697 Equity 2024: € 414,697 ▲ 8% vs 2023 (€ 385,449) Favourable step	€ 452,803 Equity 2025: € 452,803 ▲ 9% vs 2024 (€ 414,697) Favourable step	▲ 9%
Total debts	€ 483,185 Total debts 2022: € 483,185 First fiscal year in the series	€ 408,268 Total debts 2023: € 408,268 ▼ 16% vs 2022 (€ 483,185) Favourable step	€ 500,689 Total debts 2024: € 500,689 ▲ 23% vs 2023 (€ 408,268) Unfavourable step	€ 446,770 Total debts 2025: € 446,770 ▼ 11% vs 2024 (€ 500,689) Favourable step	▼ 11%
Cash	€ 131,239 Cash 2022: € 131,239 First fiscal year in the series	€ 87,557 Cash 2023: € 87,557 ▼ 33% vs 2022 (€ 131,239) Unfavourable step	€ 110,199 Cash 2024: € 110,199 ▲ 26% vs 2023 (€ 87,557) Favourable step	€ 142,887 Cash 2025: € 142,887 ▲ 30% vs 2024 (€ 110,199) Favourable step	▲ 30%
Retained profit	€ 362,803 Retained profit 2022: € 362,803 First fiscal year in the series	€ 376,765 Retained profit 2023: € 376,765 ▲ 4% vs 2022 (€ 362,803) Favourable step	€ 406,013 Retained profit 2024: € 406,013 ▲ 8% vs 2023 (€ 376,765) Favourable step	€ 444,119 Retained profit 2025: € 444,119 ▲ 9% vs 2024 (€ 406,013) Favourable step	▲ 9%
Dividend	€ 50,000 Dividend 2022: € 50,000 First fiscal year in the series	€ 65,000 Dividend 2023: € 65,000 ▲ 30% vs 2022 (€ 50,000) Unchanged	€ 120,000 Dividend 2024: € 120,000 ▲ 85% vs 2023 (€ 65,000) Unchanged	€ 150,000 Dividend 2025: € 150,000 ▲ 25% vs 2024 (€ 120,000) Unchanged	▲ 25%
Bank debt	€ 205,560 Bank debt 2022: € 205,560 First fiscal year in the series	€ 166,544 Bank debt 2023: € 166,544 ▼ 19% vs 2022 (€ 205,560) Favourable step	€ 134,869 Bank debt 2024: € 134,869 ▼ 19% vs 2023 (€ 166,544) Favourable step	€ 105,020 Bank debt 2025: € 105,020 ▼ 22% vs 2024 (€ 134,869) Favourable step	▼ 22%
Balance sheet total	€ 854,672 Balance sheet total 2022: € 854,672 First fiscal year in the series	€ 793,718 Balance sheet total 2023: € 793,718 ▼ 7% vs 2022 (€ 854,672) Unchanged	€ 915,386 Balance sheet total 2024: € 915,386 ▲ 15% vs 2023 (€ 793,718) Unchanged	€ 899,573 Balance sheet total 2025: € 899,573 ▼ 2% vs 2024 (€ 915,386) Unchanged	▼ 2%
Employees (FTE)	4.1 Employees (FTE) 2022: 4.1 First fiscal year in the series	4.7 Employees (FTE) 2023: 4.7 ▲ 0.6 vs 2022 (4.1) Unchanged	4.2 Employees (FTE) 2024: 4.2 ▼ 0.5 vs 2023 (4.7) Unchanged	4.2 Employees (FTE) 2025: 4.2 Unchanged (4.2) Unchanged

Key figures of PHARMACIE FIORE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE FIORE?

What happened at PHARMACIE FIORE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 9, 2026 New annual accounts for financial year 2025: profit of € 188,106 (▲ 26% vs 2024). Source: NBB ↗
2026 FINANCIERE DE VERVIERS stepped down as director. NBB
2021 FIANNCIERE SJSF became a director. NBB
2021 FINANCIERE DE VERVIERS became a director. NBB
Oct 4, 1973 Start of the company according to the CBE. KBO
Oct 1, 1973 New establishment in Verviers. KBO

In short

From € 100,788 profit in 2022 to € 188,106 profit in 2025.

Paid € 35,009 in corporate taxes since 2022.

Best year ever: 2025, with € 188,106 profit.

On average € 97,900 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

FINANCIERE DE VERVIERS 100%

The stake of FINANCIERE DE VERVIERS comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

PHARMACIE FIORE

Behind PHARMACIE FIORE is FIANNCIERE SJSF. The shares are held by FINANCIERE DE VERVIERS (100%).

Directors

According to the 2025 annual accounts

FIANNCIERE SJSF

Director · represented by SARAH FIORE

Also active at: FINANCIERE DE VERVIERS

since 2021

FINANCIERE DE VERVIERS

Director · represented by SARAH FIORE

since 2021 · until 2026

Shareholders

FINANCIERE DE VERVIERS

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Place du Marché 10

4800 Verviers

2.008.962.248

Thier Mère-Dieu 3

4800 Verviers

Active since 1 October 1973

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

SJSF UNIT

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0413.622.351

VAT number

BE 0413.622.351

Registered office

Place du Marché 10, 4800 Verviers

Names & denominations

PHARMACIE FIORE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

4 October 1973

Peppol

Active · Active since 8 Oct 2025

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE FIORE

Financials

What happened to PHARMACIE FIORE?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions